A 1,2-Dioxetane-Based Chemiluminescent Probe for In Vivo Copper Imaging
ACS Chemical Biology · 29.10.2026
DOI: 10.1021/acschembio.6c00617 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Chemical Biology, online erschienen am 29.10.2026. Verfasst von Rokia Osman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Southern Methodist University, Dallas, Texas75275-0314, United States. Die Arbeit nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Cancer Prevention and Research Institute of Texas, National Institutes of Health (NIH), National Science Foundation (NSF).
Abstract (Originalsprache)
Copper is involved in healthy physiology and aberrant pathology with prominent roles in Wilson’s and Menkes diseases. Tracking its reactivity in living systems is crucial to understanding its biological function and could be helpful in identifying targeted therapies. We developed a turn-on chemiluminescent copper probe CpCL, which was designed by linking a picolinic acid moiety to the phenolic substituent of a spiroadamantane 1,2-dioxetane. Reaction of CpCL with copper results in formation of a copper complex intermediate that releases the phenolate upon hydrolysis, followed by initiation of a chemiluminescence reaction for light emission. The probe displayed excellent selectivity for Cu2+ compared to other competitive metal ions, with a sensitive limit of detection of 360 nM. The mechanism was studied using initial rate kinetics to provide an estimated pseudo-first-order rate constant of 5.18 ± 0.38 × 10–5 s–1 for the hydrolysis of the copper-bound probe. The probe was then validated in living mice using the copper chelator ATN-224 as a negative control, demonstrating that it can be used to monitor copper ions in vivo.
Autor:innen und Institutionen
- Department of Chemistry, Southern Methodist University, Dallas, Texas75275-0314, United States.
- Prognostic Imaging Research Laboratory, Pre-clinical Imaging Section, Department of Radiology, UT Southwestern Medical Center, Dallas, TX75390-9058, USA.
ORCID-Profile: Ralph P Mason, Alexander R Lippert
Förderung
- Cancer Prevention and Research Institute of Texas
- National Institutes of Health (NIH)
- National Science Foundation (NSF)
Zitieren
APA
Osman, R., Griffin, C. M., Kang, Y., Mason, R. P., & Lippert, A. R. (2026). A 1,2-Dioxetane-Based Chemiluminescent Probe for In Vivo Copper Imaging. ACS Chemical Biology. https://doi.org/10.1021/acschembio.6c00617
Vancouver
Osman R, Griffin CM, Kang Y, Mason RP, Lippert AR. A 1,2-Dioxetane-Based Chemiluminescent Probe for In Vivo Copper Imaging. ACS Chemical Biology. 2026. doi:10.1021/acschembio.6c00617
BibTeX
@article{Osman2026,
author = {Osman, Rokia and Griffin, Caleb M and Kang, Yitong and Mason, Ralph P and Lippert, Alexander R},
title = {A 1,2-Dioxetane-Based Chemiluminescent Probe for In Vivo Copper Imaging},
journal = {ACS Chemical Biology},
year = {2026},
doi = {10.1021/acschembio.6c00617}
}
EUVIMED